← Back to Clinical Trials
Recruiting NCT04010188

A Registered Cohort Study on Charcot-Marie-Tooth Disease

◆ AI Clinical Summary
Plain-language summary for patients

Trial Parameters

Condition Charcot-Marie-Tooth Disease
Sponsor Ning Wang, MD., PhD.
Study Type OBSERVATIONAL
Phase N/A
Enrollment 500
Sex ALL
Min Age N/A
Max Age N/A
Start Date 2019-07-01
Completion 2039-12-31

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The aim of the study is to analyze the natural history data data from Charcot-Marie-Tooth disease and related disorders in China, to assess the clinical, genetic, epigenetic features of patients with Charcot-Marie-Tooth disease, and to optimize clinical management.

Eligibility Criteria

Inclusion Criteria: * Patients with the clinical diagnosis of Charcot-Marie-Tooth disease * Genetic diagnosis of patients with Charcot-Marie-Tooth disease * Unrelated healthy controls Exclusion Criteria: * Decline to participate. * Other peripheral neuropathy caused by trauma, immunity and toxicosis.

Related Trials

VIEW ON CLINICALTRIALS.GOV ↗ MORE CHARCOT-MARIE-TOOTH DISEASE TRIALS
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology
}